Interleukin-2 Receptor Blocking Antibody
- Name
- Interleukin-2 Receptor Blocking Antibody
- Accession Number
- DBCAT003270
- Description
Not Available
- Drugs
Drug Drug Description Basiliximab A monoclonal anti-C25 antibody (interleukin-2 receptor alpha subunit) used as immunosuppressive therapy in kidney transplant patients. Daclizumab A monoclonal anti-CD25 antibody that blocks the interleukin-2 receptor which is used to treat relapsing forms of multiple sclerosis. - Drugs & Drug Targets